Addison Wiggin

We begin today with an abject lesson in the “law of unintended consequences” — the bane of bureaucrats and world improvers the world over.

“We’re finding it in our systems, and so are other companies,” says Mark Koelmel. “So now we have to deal with this.” Mr. Koelmel runs the earth sciences unit at Chevron, the oil giant.

“This” refers to a computer virus created by the U.S. government.

The computer virus in question is Stuxnet — developed by the U.S. to cripple Iran’s nuclear capacity. Not that the U.S. government ever fessed up to that. Not officially, anyway:

“We’re glad they [the Iranians] are having trouble with their centrifuge machine,” White House arms control czar Gary Samore commented last year. “The U.S. and its allies are doing everything we can to try to make sure that we complicate matters for them.”

Unfortunately, the Iranians are no longer the only ones for whom “matters” have been “complicated.”

“I don’t think the U.S. government even realized how far [Stuxnet] had spread,” Chevron’s Koelmel tells CIO Journal. “I think the downside of what they did is going to be far worse than what they actually accomplished.”

Koelmel says Stuxnet had no adverse effects on his company — except for the man-hours required to zap the virus from the company’s computer hardware. Other companies? They’re not saying. Chevron kept its situation quiet for at least two years until The Wall Street Journal broke the story late last week.

That’s if most corporate IT departments can even recognize their systems are infected. “There are probably only 18-20 people in the country who have those fundamental skills,” says Alan Paller of the IT security research group SANS.

Good work, if you can get it, we suppose. Apart from the irony unleashed by Stuxnet, we bring it up today because it makes a fine addition to the list of 2013 “gray swans” we identified last week.

Cheers,
Addison Wiggin

The preceding article was excerpted from Agora Finacial’s 5 Min. Forecast. To read the entire episode, please feel free to do so here.

Addison Wiggin

Addison Wiggin is the executive publisher of Agora Financial, LLC, a fiercely independent economic forecasting and financial research firm. He's the creator and editorial director of Agora Financial's daily 5 Min. Forecast and editorial director of The Daily Reckoning. Wiggin is the founder of Agora Entertainment, executive producer and co-writer of I.O.U.S.A., which was nominated for the Grand Jury Prize at the 2008 Sundance Film Festival, the 2009 Critics Choice Award for Best Documentary Feature, and was also shortlisted for a 2009 Academy Award. He is the author of the companion book of the film I.O.U.S.A.and his second edition of The Demise of the Dollar, and Why it's Even Better for Your Investments was just fully revised and updated. Wiggin is a three-time New York Times best-selling author whose work has been recognized by The New York Times Magazine, The Economist, Worth, The New York Times, The Washington Post as well as major network news programs. He also co-authored international bestsellers Financial Reckoning Day and Empire of Debt with Bill Bonner.

Recent Articles

Addison Wiggin
When Genius Fails Again, Part III

Addison Wiggin

Addison Wiggin gives even more reasons why genius will fail again in part III of his series on Jim Rickards and the collapse of the financial market house of cards...


How to Bag Easy Gains from the “Mass Affluent”

Greg Guenthner

But these mass affluent sorts have the loyalty of a hooker. They'll dump one high-end brand for another at the first whiff of a better deal. And a company's profits can go poof if it doesn't figure out in advance what the hell this bunch wants next season.


Beginning to Taste the Fountain of Youth

Stephen Petranek

It is well known that the longer you live, the more likely you are to develop heart disease, stroke, osteoporosis and Alzheimer’s, to list only a few. But research out of the Salk Institute may be the clearest, most direct leap in understanding aging in the history of medical research and opens extraordinary possibilities for slowing down or even halting the aging process in humans. Stephen Petranek has more…